Komori
Intramart (3850) · FactFirst stated

Implementation of intra-mart at Taiho Pharmaceutical for quality-control operations in the pharmaceutical industry

First written in 2026-07-07. . Latest entry: 2026-07-07.

1entries
1years
1from disclosures
Share on X
How it moved
Same theme, other companies

This thread is not in a theme yet. When the same subject shows up in other companies' filings, you can compare them here.

Full recordFilings, disclosures and news, newest first
  1. 2026-07-07First statedOther Disclosures

    「We announce that Taiho Pharmaceutical has adopted イントラマート社's enterprise low-code platform※1 “intra-mart” to improve the efficiency of data use and optimize its overall business processes for the stringent quality-control operations specific to the pharmaceutical industry.」

    Achieved reductions in work time of 74% for shipment release decisions and 78% for product quality reviews. Expansion to other sites and operations and collaboration on developing packaged products for the pharmaceutical industry are planned.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Intramart's next results are scheduled for 2026-10-28. Read the earnings preview It last moved in the Other Disclosures of 2026-07-07: "First stated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.